Over the last couple of days I have been to UC Berkeley, UCLA and USC, three University of California campus, and I think that the diversity within one state encapsulates the heterogeneous bioengineering landscape I have observed on my US tour.
At UC Berkeley they look more broadly at bioengineering, with particular expertise in synthetic biology, systems biology. The Department was founded in 1998 and is the youngest Department in engineering. UC Berkeley doesn’t have a medical school so they utilise the UC San Francisco medical school for clinical/engineering collaborations, biomedical engineering research at PhD level and through the translational medicine masters program.
Day 2 was the tale of the four I’s innovation, invention, industry and impact.
All words we are aware of in the UK but the people I met at Northeastern University and MIT today are doing things a little bit differently.
From a bioengineering perspective I have already realised that it is a very heterogeneous landscape here in the USA. MIT have their very specific approach BU theres and Northeastern a different approach again.
Northeastern’s Department of Bioengineering was officially founded in January 2014, that’s not a typo that really was last month. Previously there has been, as in other institutions a lot of biomedical engineering research undertaken in different engineering Departments.